ANJAC Health & Beauty Acquires Pillar5 Pharma

Angelini Pharma Acquires Catalyst Pharmaceuticals

May 7, 2026

Healthcare Services

Angelini Pharma S.p.A. completed its acquisition of Catalyst Pharmaceuticals, Inc. for an aggregate equity value of approximately $4.1 billion (about €3.5 billion), giving Angelini ownership of Catalyst’s product portfolio and commercial infrastructure. The transaction included participation from funds managed by Blackstone and a €1 billion capital increase approved by CDP Equity, and is part of Angelini Pharma’s expansion into the U.S. brain health and rare disease market.

Ampersand Capital Partners Acquires Purna Pharmaceuticals

February 12, 2026

Healthcare Services

Ampersand Capital Partners acquired Purna Pharmaceuticals, a Belgian contract development and manufacturing provider for liquid and semi-solid pharmaceutical dosage forms. The investment is intended to enable collaboration with Ampersand portfolio company MedPharm to build a trans-Atlantic topical and transdermal drug formulation and manufacturing partnership for global pharmaceutical clients.

PCI Pharma Services Completes Acquisition of Ajinomoto Althea

May 1, 2025

Healthcare Services

PCI Pharma Services completed its acquisition of Ajinomoto Althea, a US-based sterile fill-finish CDMO and wholly owned subsidiary of Ajinomoto Co. The deal expands PCI’s aseptic fill-finish and high-potent (including ADC) manufacturing footprint, creating a large-scale hub in the San Diego region for prefilled syringes and cartridges.

Olympus Partners Acquires PAI Pharma

February 24, 2025

Pharmaceuticals

Olympus Partners has acquired PAI Pharma, a leading U.S. developer, manufacturer and distributor of generic oral liquid medicines. The platform was previously owned by Enhanced Healthcare Partners and Bourne Partners Strategic Capital; terms were not disclosed and Monroe Capital provided senior financing for the deal.

Jabil Acquires Pharmaceutics International (Pii)

February 6, 2025

Pharmaceuticals

Jabil has acquired Pharmaceutics International (Pii), a Hunt Valley, Maryland-based contract development and manufacturing organization (CDMO) that provides aseptic filling, lyophilization and oral solid dose manufacturing. The all-cash transaction represents an exit for a consortium led by Signet Healthcare Partners, Athyrium Capital Management, Hildred Capital and Pharmascience Inc., and brings Pii’s ~300+ employees and four-site campus into Jabil’s Pharmaceutical Solutions offering to expand its drug development and manufacturing capabilities.

3Pillar Global Acquires Jonah Group

September 13, 2022

Software

3Pillar Global has acquired Canada-based software engineering firm Jonah Group, adding more than 160 employees and strengthening 3Pillar's engineering capabilities and presence in Toronto's financial technology district. The acquisition expands 3Pillar's capabilities in the banking, financial services and insurance (BFSI) sector and increases its North American footprint.